Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and NeckFerris, Robert L. ; Blumenschein, George ; Fayette, Jerome ; Guigay, Joel ; Colevas, A. Dimitrios ; Licitra, Lisa ; Harrington, Kevin ; Kasper, Stefan ; Vokes, Everett E. ; Even, Caroline ; Worden, Francis ; Saba, Nabil F. ; Iglesias Docampo, Lara C. ; Haddad, Robert ; Rordorf, Tamara ; Kiyota, Naomi ; Tahara, Makoto ; Monga, Manish ; Lynch, Mark ; Geese, William J. ; Kopit, Justin ; Shaw, James W. ; Gillison, Maura L.The New England journal of medicine, 2016-11, Vol.375 (19), p.1856-1867 [Periódico revisado por pares]Texto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Treatment strategies for radioactive iodine-refractory differentiated thyroid cancerWorden, FrancisTherapeutic Advances in Medical Oncology, 2014-11, Vol.6 (6), p.267-279 [Periódico revisado por pares]London, England: SAGE PublicationsTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
A Pilot Study of Checkpoint Inhibitors in Solid Organ Transplant Recipients with Metastatic Cutaneous Squamous Cell CarcinomaTsung, Irene ; Worden, Francis P. ; Fontana, Robert J.The oncologist (Dayton, Ohio), 2021-02, Vol.26 (2), p.133-138 [Periódico revisado por pares]Hoboken, USA: John Wiley & Sons, IncTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Effect of Age on the Efficacy and Safety of Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer in the Phase III SELECT TrialBrose, Marcia S ; Worden, Francis P ; Newbold, Kate L ; Guo, Matthew ; Hurria, ArtiJournal of clinical oncology, 2017-08, Vol.35 (23), p.2692-2699 [Periódico revisado por pares]United StatesTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trialSacco, Assuntina G ; Chen, Ruifeng ; Worden, Francis P ; Wong, Deborah J L ; Adkins, Douglas ; Swiecicki, Paul ; Chai-Ho, Wanxing ; Oppelt, Peter ; Ghosh, Debanjali ; Bykowski, Julie ; Molinolo, Alfredo ; Pittman, Emily ; Estrada, M Valeria ; Gold, Kathryn ; Daniels, Gregory ; Lippman, Scott M ; Natsuhara, Amanda ; Messer, Karen ; Cohen, Ezra E WThe lancet oncology, 2021-06, Vol.22 (6), p.883-892 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II StudyBauml, Joshua ; Seiwert, Tanguy Y ; Pfister, David G ; Worden, Francis ; Liu, Stephen V ; Gilbert, Jill ; Saba, Nabil F ; Weiss, Jared ; Wirth, Lori ; Sukari, Ammar ; Kang, Hyunseok ; Gibson, Michael K ; Massarelli, Erminia ; Powell, Steven ; Meister, Amy ; Shu, Xinxin ; Cheng, Jonathan D ; Haddad, RobertJournal of clinical oncology, 2017-05, Vol.35 (14), p.1542-1549 [Periódico revisado por pares]United States: American Society of Clinical OncologyTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trialAdkins, Douglas, Prof ; Ley, Jessica, BS ; Neupane, Prakash, MD ; Worden, Francis, Prof ; Sacco, Assuntina G, MD ; Palka, Kevin, MD ; Grilley-Olson, Juneko E, MD ; Maggiore, Ronald, MD ; Salama, Noha N, PhD ; Trinkaus, Kathryn, PhD ; Van Tine, Brian A, MD ; Steuer, Conor E, MD ; Saba, Nabil F, Prof ; Oppelt, Peter, MDThe lancet oncology, 2019-09, Vol.20 (9), p.1295-1305 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Survival Prognostication in Patients with Differentiated Thyroid Cancer and Distant Metastases: A SEER Population-Based StudyChen, Debbie ; Carr, Grant ; Worden, Francis Paul ; Veenstra, Christine M ; Haymart, Megan R ; Banerjee, MousumiThyroid (New York, N.Y.), 2024-07, Vol.34 (7), p.837-845 [Periódico revisado por pares]United StatesTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Molecularly targeted therapy for the treatment of head and neck cancer: a review of the ErbB family inhibitorsSacco, Assuntina G ; Worden, Francis POncoTargets and therapy, 2016-01, Vol.9, p.1927-1943 [Periódico revisado por pares]New Zealand: Dove Medical Press LimitedTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Efficacy of Selpercatinib in RET-Altered Thyroid CancersWirth, Lori J ; Sherman, Eric ; Robinson, Bruce ; Solomon, Benjamin ; Kang, Hyunseok ; Lorch, Jochen ; Worden, Francis ; Brose, Marcia ; Patel, Jyoti ; Leboulleux, Sophie ; Godbert, Yann ; Barlesi, Fabrice ; Morris, John C ; Owonikoko, Taofeek K ; Tan, Daniel S.W ; Gautschi, Oliver ; Weiss, Jared ; de la Fouchardière, Christelle ; Burkard, Mark E ; Laskin, Janessa ; Taylor, Matthew H ; Kroiss, Matthias ; Medioni, Jacques ; Goldman, Jonathan W ; Bauer, Todd M ; Levy, Benjamin ; Zhu, Viola W ; Lakhani, Nehal ; Moreno, Victor ; Ebata, Kevin ; Nguyen, Michele ; Heirich, Dana ; Zhu, Edward Y ; Huang, Xin ; Yang, Luxi ; Kherani, Jennifer ; Rothenberg, S. Michael ; Drilon, Alexander ; Subbiah, Vivek ; Shah, Manisha H ; Cabanillas, Maria EThe New England journal of medicine, 2020-08, Vol.383 (9), p.825-835 [Periódico revisado por pares]United States: Massachusetts Medical SocietyTexto completo disponível |